Morgan Stanley’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.38M | Buy |
|
|||||
|
2025
Q1 | $71.8K | Buy |
|
|||||
|
2024
Q4 | $16.4K | Sell |
|
|||||
|
2024
Q3 | $21.8K | Buy |
|
|||||
|
2024
Q2 | $3.92K | Buy |
|
|||||
|
2024
Q1 | $1.43K | Sell |
|
|||||
|
2023
Q4 | $3.01K | Buy |
|
|||||
|
2023
Q3 | $3.97K | Sell |
|
|||||
|
2023
Q2 | $13.2K | Buy |
|
|||||
|
2023
Q1 | $7.72K | Sell |
|
|||||
|
2022
Q4 | $131K | Buy |
|
|||||
|
2022
Q3 | $108K | Sell |
|
|||||
|
2022
Q2 | $204K | Buy |
|
|||||
|
2022
Q1 | $610K | Sell |
|
|||||
|
2021
Q4 | $686K | Sell |
|
|||||
|
2021
Q3 | $1.69M | Buy |
|
|||||
|
2021
Q2 | $172K | Buy |
|
|||||
|
2021
Q1 | $33K | Buy |
|
|||||
|
2020
Q4 | $10K | Sell |
|
|||||
|
2020
Q3 | $7K | Sell |
|
|||||
|
2020
Q2 | $9K | Sell |
|
|||||
|
2020
Q1 | $60K | Buy |
|
|||||
|
2019
Q4 | $7K | Buy |
|
|||||
|
2019
Q3 | $7K | Buy |
|
|||||
|
2019
Q2 | $5K | Buy |
|
|||||
|
2019
Q1 | $31K | Buy |
|
|||||
|
2018
Q4 | $34K | Buy |
|
|||||
|
2018
Q3 | $32K | Hold |
|
|||||
|
2018
Q2 | $90K | Hold |
|
|||||
|
2018
Q1 | $91K | Buy |
|
|||||
|
2017
Q4 | $10K | Buy |
|
|||||
|
2017
Q3 | $12K | Sell |
|
|||||
|
2017
Q2 | $47K | Buy |
|
|||||
|
2017
Q1 | $45K | Buy |
|
|||||
|
2016
Q4 | $128K | Buy |
|